Arkolith/Insider Trading/CLSD/Form 4

Whitmore Bradford T

10% OwnerClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Feb 9, 2024
Net Buying
Open-Market Buys
$600K
Open-Market Sells
$0
Net Open-Market Flow
$600K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2024Buy(P)444K$1.35$600K4.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 7, 2024Buy(P)444K—$0444K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000933430-24-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML